A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis.

Trial Profile

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jan 2012

At a glance

  • Drugs NB 001 (Primary)
  • Indications Herpes labialis
  • Focus Registrational; Therapeutic Use
  • Acronyms SHaRCS
  • Most Recent Events

    • 16 Jan 2012 Actual patient number (847) added as reported by ClinicalTrials.gov.
    • 16 Jan 2012 Actual end date (January 2012) added as reported by ClinicalTrials.gov.
    • 16 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top